Multiple myeloma is a cancer of plasma cells that produce monoclonal immunoglobulin, and the neoplastic plasma cells typically accumulate in the bone marrow with occasional involvement of other organs. Pleural effusion that is associated with multiple myeloma has been infrequently reported (＜6%) and myelomatous pleural effusion is extremely rare (＜1%). A 73-year-old woman was admitted to the department of dermatology for skin lesions on both arms and both ankles. A chest radiograph taken on admission showed a nodular lesion in the right upper lung and pleural effusion. Analysis of the pleural fluid revealed many atypical plasma cells, elevated levels of IgA (27.95g/L) and lambda light chain (9.16g/L), and monoclonal IgA-lambda paraprotein on immunofixation. The serum concentrations of IgA were elevated (33.08g/L) while the concentrations of IgG and IgM were decreased. Bone marrow aspirate smears contained increased levels of immature-appearing atypical plasma cells. This is only the third case of myelomatous pleural effusion that has been reported in Korea. (Korean J Hematol 2006;41:41-45.) 
INTRODUCTION
Multiple myeloma (MM) is a disease in which neoplastic plasma cells accumulate in the bone marrow and generally produce a monoclonal immunoglobulin, usually of type IgG or IgA. 1) Malignant plasma cells may also affect other organs. Although the involvement of rib and sternum is relatively common, associated pulmonary parenchymal or pleural disease has been reported infrequently. 2, 3) Pleural effusion in MM has been reported in less than 6% of cases and myelomatous pleural effusion (MPE) is extremely rare (＜1%). 4, 5) MPE is most commonly associated with IgA or IgG myeloma and very rarely with IgD or light chain myeloma. [6] [7] [8] [9] Only two cases of MPE associated with MM have been reported in Korea to date: one with IgG-kappa and the other with IgD-lambda myeloma. 3, 9) The present study involves a patient with IgA-lambda MM who presented with skin lesions and pleural effusion. 
CASE REPORT
A 73-year-old woman was admitted to the dermatology department for skin lesions on both of her arms and ankles. She had been followed up in the dermatology department for 7 months for evaluation of erythematous macules and papules on her arm. Her symptoms persisted and the lesions spread to the lower extremities. No remarkable findings were seen on physical examination other than edematous ankles with tenderness of the newly developed lesions. A punch biopsy of the leg on the second hospital day revealed leukocytoclastic vasculitis (LCV) with multiple fibrin thrombi. On the seventh day, the patient complained of swelling of the right arm and a soft and fixed mass was incidentally found on the frontal scalp area. Punch biopsy of the scalp lesion showed mild superficial perivenular lymphocytic infiltration. A breast ultrasonogram was performed to determine the cause of edema, indicating multiple lymph node enlargement of the right axilla and a huge multiseptated mass at the right supraclavicular area, suggestive of a possible malignant lymphoma, metastatic malignant lesion, or tuberculosis. A fine needle aspiration biopsy of the axillary lymph node showed diffuse infiltration of mature and immature plasma cells, consistent with plasma cell myeloma. The right supraclavicular mass appeared malignant, with possible pathologic diagnoses of extraosseous plasmocytoma with metastasis, malignant lymphoma, inflammatory reactive lymphadenopathy or metastatic malignancy involving lymph nodes from lung, breast, or stomach cancer. The follow up was lost because the patient was transferred to another hospital for further treatment.
DISCUSSION
We report a case of late stage MM with associated malignant pleural effusion, leukocytoclastic vasculitis and lymphedema. The most common cause of the MM-related pleural effusion is congestive heart failure, due to either amyloidosis or atherosclerotic heart disease. Other less common causes include pulmonary embolism, chronic renal failure, a second neoplasm, and myelomatous pleural invovement. 10) Malignant pleural effusion in MM is extremely rare, occurring in less than 1% of patients. 4) In Korea, only two cases of myeloma with associated MPE have been reported to date, one IgG-kappa and one IgD-lambda, 3, 9) and its prevalence has not been reported. In the present study, myelomatous effusion was diagnosed by detection of IgA-lambda type monoclonal immunoglobulin and atypical plasma cells in the pleural fluid. It should be noted that protein electrophoresis of pleural fluid may be unreliable since hemorrhagic effusions are common, and pleural biopsy may show a low diagnostic yield of plasma cell infiltrates due to frequent non-uniform pleural involvement. 11) The differential diagnoses based on the morphology of plasma cells in pleural effusion include MM, lymphoma with plasmacytic differentiation, and metastatic non-hematolymphoid neoplasia such as melanoma and neuroendocrine carcinoma. IgA gammopathy is more frequently represented in MM cases with MPE, 12) implying a difference in propensity to develop MPE according to the type of paraprotein. Pleural effusion is indicative of a dismal prognosis in MM and generally represents a late complication of progressive and disseminated disease. [10] [11] [12] Patients with MPE usually respond poorly to available therapy and the mortality rate reaches 90% within 1 year. In a recent report of 11 patients who developed MPE approximately 12 months after being diagnosed with MM, the median survival was 4 months from the onset of MPE, suggesting that MPE in MM is often associated with a poor prognosis despite aggressive local and systemic treatment. 12) LCV is an inflammatory necrotizing disease of the superficial dermal vessels that is associated with a variety of diseases including infections, drug reactions, connective tissue disorders, ANCAassociated vasculitides, as well as malignancies involving both solid tumors and lymphoproliferative disorders. 13) Since LCV has been observed in association with so many disease states, it has been difficult to clarify the relationship between LCV and malignancies. However, the cutaneous manifestation of the patient in this study may have been associated with late stage MM, since she did not have any apparent connective tissue disorders or ANCA-associated vasculitides. Cytokine elease by tumor cells, which induces an immunologic reaction against vascular smooth muscle cells, is one of several pathogenic mechanisms that have been proposed to explain this connection. 14) It has also been suggested that patients with a poorer prognosis or with late stage MM may be predisposed towards the development of LCV due to an increased immunologic response. 14) In conclusion, recognition of the malignant nature of the pleural effusion is of great importance for therapeutic and prognostic considerations and can be achieved by cytological examination, immunoelectrophoresis, and flow cytometric analysis of the pleural fluid. Likewise, a screening examination to detect any underlying neoplasms may be warranted in elderly patients with apparently idiopathic cutaneous LCV and clinical symptoms suggestive of malignancy. 
